TW200605917A - Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation - Google Patents

Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation

Info

Publication number
TW200605917A
TW200605917A TW094114826A TW94114826A TW200605917A TW 200605917 A TW200605917 A TW 200605917A TW 094114826 A TW094114826 A TW 094114826A TW 94114826 A TW94114826 A TW 94114826A TW 200605917 A TW200605917 A TW 200605917A
Authority
TW
Taiwan
Prior art keywords
spray
linked
dried powder
saccharose
derivative
Prior art date
Application number
TW094114826A
Other languages
English (en)
Chinese (zh)
Inventor
Stefan Bassarab
Karoline Bechtold-Peters
Richard Fuhrherr
Wolfgang Friess
Patrick Garidel
Torsten Schultz-Fademrecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of TW200605917A publication Critical patent/TW200605917A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
TW094114826A 2004-05-10 2005-05-09 Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation TW200605917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004022926A DE102004022926A1 (de) 2004-05-10 2004-05-10 Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
TW200605917A true TW200605917A (en) 2006-02-16

Family

ID=34966513

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094114826A TW200605917A (en) 2004-05-10 2005-05-09 Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation

Country Status (7)

Country Link
EP (1) EP1778188A1 (fr)
JP (1) JP2007536313A (fr)
KR (1) KR20070037441A (fr)
CA (1) CA2564324A1 (fr)
DE (1) DE102004022926A1 (fr)
TW (1) TW200605917A (fr)
WO (1) WO2005112892A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
AU2006328385B2 (en) * 2005-12-21 2011-08-25 Eisai R & D Management Co., Ltd. Amorphous form of 1,2-dihydropyridine compound
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
WO2010133294A2 (fr) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapteur, dispositif d'inhalation et nébuliseur
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
CN102686260B (zh) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 喷雾器
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3139979B1 (fr) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unité, nébuliseur et procédé
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
CA2965759C (fr) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5012272A (fr) * 1973-06-01 1975-02-07
EP0447125B1 (fr) * 1990-03-08 1995-07-19 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Procédé pour préparer une poudre à contenu élevé de lactosucrose et utilisation de cette poudre
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
DE69532110T2 (de) * 1994-01-31 2004-09-09 Yamanouchi Pharmaceutical Co., Ltd. Intraoral löslicher formpressling und verfahren zu seiner herstellung
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
US5922324A (en) * 1995-01-31 1999-07-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Propolis extract with improved water-solubility
US5892026A (en) * 1995-04-12 1999-04-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo High Trehalose content syrup
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
DE19732351A1 (de) * 1997-07-28 1999-02-04 Hoechst Ag Verfahren zur Herstellung der Süßkraft und zur Geschmacksverbesserung einer Mischung hochintensiver Süßstoffe
DE60127175T2 (de) * 2000-12-21 2007-11-08 Nektar Therapeutics, San Carlos Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor

Also Published As

Publication number Publication date
JP2007536313A (ja) 2007-12-13
WO2005112892A1 (fr) 2005-12-01
EP1778188A1 (fr) 2007-05-02
KR20070037441A (ko) 2007-04-04
DE102004022926A1 (de) 2005-12-15
CA2564324A1 (fr) 2005-12-01

Similar Documents

Publication Publication Date Title
TW200605917A (en) Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation
TW200605905A (en) 1,4 o-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
TW200605897A (en) Powder comprising new compositions of oligosaccharides and methods for their preparation
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2007090882A3 (fr) Compositions pharmaceutiques
HK1076605A1 (en) Formulations
WO2005046603A3 (fr) Composes pyridiniques
MXPA03010207A (es) Nuevas 4-anilinoquinolin-3-carboxamidas.
NO20050828L (no) lndol-3-svovelderivater
WO2002074247A3 (fr) Formulations pharmaceutiques a liberation prolongee
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
NO20051414L (no) Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger
WO2006096444A3 (fr) Composes chimiques
AR033711A1 (es) Composiciones farmaceuticas
WO2001029055A3 (fr) Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
WO2004093800A3 (fr) Derives de thyronamine et analogues et des methodes d'utilisation de ces composes
WO2006028810A3 (fr) Procede de cicatrisation de plaies a l'aide d'antagonistes du recepteur d'adenosine a2b
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2007087026A3 (fr) Forme solide de amg 706 et compositions pharmaceutiques contenant ledit composé
WO2004098594A3 (fr) Forme posologique contenant du pantoprazole en tant qu'ingredient actif
WO2001000617A3 (fr) Nouveaux derives de piperazinyl-alkyl-thiopyrimidine compositions pharmaceutiques les contenant et procede de preparation de la substance active
WO2004098577A3 (fr) Forme posologique contenant du (s)-pantoprazole en tant qu'ingredient actif